Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
作者:
主题词
成年人(Adult);动物(Animals);抗高血压药(Antihypertensive Agents);细胞凋亡(Apoptosis);印迹法, 蛋白质(Blotting, Western);骨形态发生蛋白受体, Ⅱ型(Bone Morphogenetic Protein Receptors, Type II);钙(Calcium);细胞增殖(Cell Proliferation);细胞, 培养的(Cells, Cultured);去氢表雄酮(Dehydroepiandrosterone);疾病模型, 动物(Disease Models, Animal);酶激活(Enzyme Activation);女(雌)性(Female);人类(Humans);高血压, 肺性(Hypertension, Pulmonary);原位缺口末端标记(In Situ Nick-End Labeling);凋亡抑制蛋白质类(Inhibitor of Apoptosis Proteins);男(雄)性(Male);膜电位, 线粒体(Membrane Potential, Mitochondrial);微RNAs(MicroRNAs);微管相关蛋白质类(Microtubule-Associated Proteins);中年人(Middle Aged);野百合碱(Monocrotaline);肌, 平滑(Muscle, Smooth);肌细胞, 平滑肌(Myocytes, Smooth Muscle);NFATC转录因子类(NFATC Transcription Factors);原癌基因蛋白质c-pim-1(Proto-Oncogene Proteins c-pim-1);肺动脉(Pulmonary Artery);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);STAT3转录因子(STAT3 Transcription Factor);信号传导(Signal Transduction);血管舒张药(Vasodilator Agents);src族激酶类(src-Family Kinases)
DOI
10.1152/ajpheart.00654.2011
PMID
21890685
发布时间
2022-06-09
- 浏览34
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文